Metabolic syndrome: Pathogenesis, medical care and dental implications

Journal of the American Dental Association

Volumn 138, Issue 2, 2007, Pages 179-187

  Friedlander, Arthur H ^a,b   Weinreb, Jane ^a,c,d   Friedlander, Ida ^e   Yagiela, John A ^b,d  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Diabetes Program

^d UNIVERSITY OF CALIFORNIA   (United States)

^e North Hollywood Health Center   (United States)

Author keywords

Atherosclerosis; Hypertension; Metabolic syndrome; Obesity

Indexed keywords

EID: 33847720232     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2007.0134     Document Type: Article

References (80)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel III). JAMA 2001;285(19):2486-97.
2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112(17):2735-52.
3. Genuth S, Alberti KG, Bennett P, et al.; The Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26(11):3160-7.
4. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004;109(1):42-6.
5. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004;173(2):307-14.
6. Laaksonen DE. Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and the development of diabetes mellitus: application and validation of recently suggested definitions of metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156(11):1070-7.
7. Hertz RP, Unger AN, McDonald M, Lustik MB, Biddulph-Krentar J. The impact of obesity on work limitations and cardiovascular risk factors in the U.S. workforce. J Occup Environ Med 2004;46(12): 1196-203.
8. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004;2(10)7: 2444-9.
9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287(3):356-9.
10. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110(10):1245-50.
11. Ford ES, Kohl HW, Mokdad AH, Ajani UA. Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults. Obes Res 2005;13(3):608-14.
12. Ginsberg HN. Treatment for patients with the metabolic syn drome. Am J Cardiol 2003;91(7A):29E-39E.
13. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46(1):3-10.
14. Isomaa B. A major health hazard: the metabolic syndrome. Life Sci 2003;73(19):2395-411.
15. Fisher EA, Ginsberg HN. Complexity in the secretory pathway: the assembly and secretion of apoliprotein B-containing lipoproteins. J Biol Chem 2002;277(20):17377-80.
16. Berglund L, Hyson D. Cholesterol absorption and the metabolic syndrome: a new look at an old area. Arterioscler Thromb Vase Biol 2003;23(8):1314-6.
17. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86(2):713-8.
18. Scott CL. Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Cardiol 2003;92(1A):35i-42i.
19. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004;89(1):108-13.
20. Hulthe J, Bokemark L, Wikstrand J, Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vase Biol 2000;20(9):2140-7.
21. Deedwania PC. Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease? Circulation 2004;109(1):2-4.
22. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53(8):2087-94.
23. Wong ND. Intensified screening and treatment of the metabolic syndrome for cardiovascular risk reduction. Prev Cardiol 2005;8(1): 47-52.
24. Laaksonen DE, Niskanen L, Lakka H-M, Lakka TA, Uusitupa M. Epidemiology and treatment of the metabolic syndrome. Ann Med 2004;36(5):332-46.
25. Pritchett AM, Foreyt JP, Mann DL. Treatment of the metabolic syndrome: the impact of lifestyle modification. Curr Atheroscler Rep 2005;7(2):95-102.
26. Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002;4(6):407-14.
27. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004;109(4):551-6.
28. Plodkowski RA, Krenkel J. Combined treatment for obesity and the metabolic syndrome. J Am Diet Assoc 2005;105(5 supplement 1):S124-S130.
29. Brooks GA, Butte NF, Rand WM, Flatt JP, Caballero B. Chronicle of the Institute of Medicine physical activity recommendation: how a physical activity recommendation came to be among dietary recommendations. Am J Clin Nutr 2004;79(5):921S-930S.
30. Roberts WC. The metabolic syndrome. Am J Cardiol 2004;93(2):274.
31. Gaciong Z, Placha G. Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open label, observational study. J Hum Hypertens 2005;19(9):737-43.
32. Maki KC. Fimbrates for treatment of the metabolic syndrome. Curr Atheroscler Rep 2004;6(1):45-51.
33. Isaacsohn J, Hunninghake D, Schrott H, et al. Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia. Clin Cardiol 2003;26(1):18-24.
34. Sowers JR. Effects of statins on the vasculature: implications for aggressive lipid management in the cardiovascular metabolic syndrome. Am J Cardiol 2003;91(4A):14B-22B.
35. Wagh A, Stone NJ. Treatment of metabolic syndrome. Expert Rev Cardiovasc Ther 2004;2(2):213-28.
36. Deedwania PC, Volkova N. Current treatment options for metabolic syndrome. Curr Treat Options Cardiovasc Med 2005;7(1):61-74.
37. Daskalopoulou SS, Mikhailidis DP, Elisaf M. Prevention and treatment of the metabolic syndrome. Angiology 2004;55(6):589-612.
38. Pearson TA, Mensah GA, Alexander RW, et al.; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107(3):499-511.
39. Ritchie CS. Oral health, taste, and olfaction. Clin Geriatr Med 2002;18(4):709-17.
40. Ritchie CS, Joshipura K, Hung HC, Douglass CW. Nutrition as a mediator in the relation between oral and systemic disease: associations between specific measures of adult oral health and nutrition outcomes. Crit Rev Oral Biol Med 2002;13(3):291-300.
41. Lowe G, Woodward M, Rumley A, Morrison C, Tunstall-Pedoe H, Stephen K. Total tooth loss and prevalent cardiovascular disease in men and women: possible roles of citrus fruit consumption, vitamin C, and inflammatory and thrombic variables. J Clin Epidemiol 2003;56(7):697-700.
42. Hung HC, Colditz G, Joshipura KJ. The association between tooth loss and the self-reported intake of selected CVD-related nutrients and foods among US women. Community Dent Oral Epidemiol 2005;33(3):167-73.
43. Norlen P, Steen B, Birkhed D, Bjorn AL. On the relations between dietary habits, nutrients, and oral health in women at the age of retirement. Acta Odontol Scand 1993;51(5):277-84.
44. Joshipura KJ, Willett WC, Douglass CW. The impact of edentulousness on food and nutrient intake. JADA 1996;127(4):459-67.
45. Papas AS, Palmer CA, Rounds MC, Russell RM. The effects of denture status on nutrition. Spec Care Dentist 1998;18(1):17-25.
46. Papas AS, Joshi A, Giunta JL, Palmer C. Relationships among education, dentate status, and diet in adults. Spec Care Dentist 1998;18(1):26-32.
47. Hung HC, Willett W, Ascherio A, Rosner BA, Rimm E, Joshipura KJ. Tooth loss and dietary intake. JADA 2003;134(9):1185-92.
48. Sahyoun NR, Lin C-L, Krall E. Nutritional status of the older adult is associated with dentition status. J Am Diet Assoc 2003;103(1):61-6.
49. Johansson I, Tidehag P, Lundberg V, Hallmans G. Dental status, diet and cardiovascular risk factors in middle-aged people in northern Sweden. Community Dent Oral Epidemiol 1994;22(6):431-6.
50. Forslund HB, Lindroos AK, Blomkvist K, et al. Number of teeth, body mass index, and dental anxiety in middle-aged Swedish women. Acta Odontol Scand 2002;60(6):346-52.
51. Nowjack-Raymer RE, Sheiham A. Association of edentulism and diet and nutrition in US adults. J Dent Res 2003;82(2):123-6.
52. Sheiham A, Steele JG, Marcenes W, et al. The relationship among dental status, nutrient intake, and nutritional status in older people. J Dent Res 2001;80(2):408-13.
53. Krall E, Hayes C, Garcia R. How dentition status and masticatory function affect nutrient intake. JADA 1998;129(9):1261-9.
54. Akeel R, Nilner M, Nilner K. Masticatory efficiency in individuals with natural dentition. Swed Dent 1992;16(5):191-8.
55. Gunne HS. Masticatory efficiency and dental state: a comparison between two methods. Acta Odontol Scand 1985;43(3):139-46.
56. Mowlana F, Heath MR, Van der Bilt A, Van der Glas HW. Assessment of chewing efficiency: a comparison of particle size distribution determined using optical scanning and sieving of almonds. J Oral Rehabil 1994;21(5):545-51.
57. Sheiham A, Steele JG, Marcenes W, Tsakos G, Finch S, Walls AW. Prevalence of impacts of dental and oral disorders and their effects on eating among older people; a national survey in Great Britain. Community Dent Oral Epidemiol 2001;29(3): 195-203.
58. Lindquist LW. Prosthetic rehabilitation of the edentulous mandible: a longitudinal study of treatment with tissue-integrated fixed prosthetics. Swed Dent J Suppl 1987;48:1-39.
59. Moynihan PJ, Butler TJ, Thomason JM, Jepson NJ. Nutrient intake in partially dentate patients: the effect of prosthetic rehabilitation. J Dent 2000;28(8):557-63.
60. Morais JA, Heydecke G, Pawliuk J, Lund JP, Feine JS. The effects of mandibular two-implant overdentures on nutrition in elderly edentulous individuals. J Dent Res 2003;82(1):53-8.
61. Grimble RF. Nutritional modulation of cytokine biology. Nutrition 1998;14(7-8):634-40.
62. Nappo P, De Rosa N, Marfella R, et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999;281(22):2113-8.
63. Nuttall SL, Kendall MJ, Martin U. Antioxidant therapy for prevention of cardiovascular disease. QJM 1999;92(5):239-44.
64. Cox BD, Whichelow MJ, Prevost AT. Seasonal consumption of salad vegetables and fresh fruit in relation to the development of cardiovascular disease and cancer. Public Health Nutr 2000;3(1):19-29.
65. Joshipura KJ, Hu FB, Manson JE, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001;134(12):1106-14.
66. Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999;282(13): 1233-9.
67. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus - provisional report of a WHO consultation. Diabet Med 1998;15(7):539-53.
68. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999:1-38.
69. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9(3):237-52.
70. Physicians' desk reference. 59th ed. Montvale, N.J.: Medical Economics; 2005.
71. McEvoy GK, ed. AHFS drug information 2005. Bethesda, Md.: American Society of Health-System Pharmacists; 2005.
72. Wynn RL, Meiller TF, Crossley HL, eds. Drug information for dentistry: Oral medicine for medically-compromised patients and specific oral conditions. 9th ed. Hudson, Ohio: Lexi-Comp; 2003.
73. Zieve FJ. The metabolic syndrome: diagnosis and treatment. Clin Cornerstone 2004;6(supplement 3):S5-S13.
74. Dunn RT, Ford MA, Rindone JP, Kwiecinski FA. Low-dose aspirin and ibuprofen reduce the cutaneous reactions following niacin administration. Am J Ther 1995;2(7):478-80.
75. Speechley JA, Rugman FP. Some problems with anticoagulants in dental surgery. Dent Update 1992;19(5):204-6.
76. Brugemann J, van Gelder IC, van der Meer J, Zijlstra F. Cardiological (pharmaco) therapy and dental practice (in Dutch). Ned Tijdschr Tandheelkd 2006;113(2):75-81.
77. Cahill RA, McGreal GT, Crowe BH, et al. Duration of increased bleeding tendency after cessation of aspirin therapy. J Am Coll Surg 2005;200(4):564-73.
78. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuatio: review and meta-analysis. J Intern Med 2005;257(5):399-414.
79. Madan GA, Madan SG, Madan G, Madan AD. Minor oral surgery without stopping daily low-dose aspirin in therapy: a study of 51 patients. J Oral Maxillofac Surg 2005;63(9):1262-5.
80. Ardekian L, Gaspar R, Peled M, Brener B, Laufer D. Does low dose aspirin therapy complicate oral surgical procedures? JADA 2000;131(3):331-5.